Skip to main content
RSNA Journals logoLink to RSNA Journals
. 2019 Feb 19;291(1):149–157. doi: 10.1148/radiol.2019181042

High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra

Zheng Zhong 1, Douglas Merkitch 1, M Muge Karaman 1, Jiaxuan Zhang 1, Yi Sui 1, Jennifer G Goldman 1, Xiaohong Joe Zhou 1,
PMCID: PMC6438360  PMID: 30777809

Abstract

Background

Motor symptoms in Parkinson disease (PD) have exhibited lateral asymmetry, suggesting asymmetric neuronal loss in the substantia nigra (SN). Diffusion MRI may be able to help confirm tissue microstructural alterations in the substantia nigra to probe for the presence of asymmetry.

Purpose

To investigate lateral asymmetry in the SN of patients with PD by using diffusion MRI with both Gaussian and non-Gaussian models.

Materials and Methods

In this cross-sectional study conducted from March 2015 to March 2017, 27 participants with PD and 27 age-matched healthy control (HC) participants, all right handed, underwent MRI at 3.0 T. High-spatial-resolution diffusion images were acquired with a reduced field of view by using seven b values up to 3000 sec/mm2. A continuous-time random-walk (CTRW) non-Gaussian diffusion model was used to produce anomalous diffusion coefficient (Dm) and temporal (α) and spatial (β) diffusion heterogeneity indexes followed by a Gaussian diffusion model to yield an apparent diffusion coefficient (ADC). Individual or linear combinations of diffusion parameters in the SN were unilaterally and bilaterally compared between the PD and HC groups.

Results

In the bilateral comparison between the PD and HC groups, differences were observed in β (0.67 ± 0.06 [standard deviation] vs 0.64 ± 0.04, respectively; P = .016), ADC (0.48 μm2/msec ± 0.08 vs 0.53 μm2/msec ± 0.06, respectively; P = .03), and the combination of CTRW parameters (P = .02). In the unilateral comparison, differences were observed in all diffusion parameters on the left SN (P < .03), but not on the right (P > .20). In a receiver operating characteristic (ROC) analysis to delineate left SN abnormality in PD, the combination of Dm, α, and β produced the best sensitivity (sensitivity, 0.78); the combination of Dm and β produced the best specificity (specificity, 0.85); and the combination of α and β produced the largest area under the ROC curve (area under the ROC curve, 0.73).

Conclusion

These results suggest that quantitative diffusion MRI is sensitive to brain tissue changes in participants with Parkinson disease and provide evidence of substantia nigra lateral asymmetry in this disease.

© RSNA, 2019

Online supplemental material is available for this article.


Summary

By using high-spatial-resolution diffusion MRI that was sensitive to tissue microstructures, significant changes of diffusion parameters were observed only on the left side of substantia nigra of right-handed patients with Parkinson disease.

Key Points

  • ■ Diffusion characteristics of the substantia nigra were different in patients with Parkinson disease compared with healthy control participants.

  • ■ Differences in all diffusion parameters in Parkinson disease were localized to the left substantia nigra (P < .03) compared with healthy control participants in right-handed participants, suggesting lateral asymmetry of the substantia nigra in Parkinson disease.

Introduction

Parkinson disease (PD) is a neurodegenerative disorder characterized by progressive degeneration of dopaminergic neurons in the substantia nigra (SN), leading to abnormalities of movement and other functions. Motor symptoms in PD onset and progression have exhibited lateral asymmetry (1), which suggests that the neuronal loss in the SN can be asymmetric, as reported in a neuropathologic study (2). In a majority of patients, symptoms begin on the side of the dominant hand (1). SPECT has demonstrated left hemispheric predominance of nigrostriatal dysfunction in patients with PD who are right handed, providing further evidence that dopaminergic denervation in the SN can be asymmetric (3). Furthermore, signal lateral asymmetry in the SN was indicated in an anatomic MRI study at 7.0 T (4) and considered in a susceptibility-weighted imaging study at 3.0 T (5). Neuroimaging evidence of underlying tissue microstructural alterations in the SN, particularly with the presence of asymmetry, ultimately may help detect those at risk for PD or exhibiting prodromal or mild motor symptoms, and identify who would be candidates for potential future disease-modifying therapies.

Diffusion MRI emerged as an important tool to probe tissue microstructures. Apparent diffusion coefficient (ADC) from diffusion-weighted imaging and fractional anisotropy and mean diffusivity from diffusion-tensor imaging have been used extensively to study brain tissue alterations, including those in PD (69). ADC, fractional anisotropy, and mean diffusivity are derived from a monoexponential diffusion model, which assumes that diffusion displacement of water molecules follows a Gaussian distribution. However, this assumption breaks down as tissue structural complexity becomes greater (1014), particularly when measured at high b values (eg, b > 1500 sec/mm2 in brain tissues), leading to non-Gaussian diffusion displacement. A number of non-Gaussian diffusion models have been developed to probe various aspects of tissue microstructures (1016). Among these models, the continuous-time random-walk (CTRW) model (14) is of particular interest because it offers two new parameters related to temporal diffusion heterogeneity (α) and spatial diffusion heterogeneity (β) that can be linked to intravoxel tissue structural heterogeneities, thereby providing an avenue to studying microstructural alterations in the human brain.

Gaussian or non-Gaussian diffusion imaging is typically performed by using a single-shot echo-planar imaging pulse sequence to shorten acquisition times and reduce motion sensitivity. However, conventional single-shot echo-planar imaging offers limited spatial resolution and is subject to image distortion, which causes challenges for studying small structures located in the distortion-prone areas such as the brainstem that contains the SN. The spatial resolution can be substantially improved by restricting the field of view, which was demonstrated by the use of two-dimensional radiofrequency excitation pulses (1720). Additionally, the reduced field-of-view technique also lessens geometric distortion from magnetic susceptibility variations.

In this study, we hypothesized that if the structural abnormalities in the SN in patients with PD were laterally asymmetric, it would be represented by an asymmetry in diffusion. Therefore, our aim was to investigate the possible lateral asymmetry by using a high-spatial-resolution reduced field-of-view diffusion imaging sequence with a Gaussian (ie, the monoexponential) and a non-Gaussian diffusion model (ie, the CTRW model).

Materials and Methods

Participants

This cross-sectional study was approved by the institutional review board of the University of Illinois at Chicago and Rush University in accordance with Health Insurance Portability and Accountability Act guidelines. All participants provided written informed consent for the study, which was conducted from March 2015 to March 2017.

Thirty-four participants with PD were recruited by convenience from the Rush University Movement Disorder Clinic as part of an ongoing study of clinical and neuroimaging markers of cognitive and behavioral symptoms related to PD (21). All participants with PD were examined by a movement disorders neurologist (J.G.G., with more than 15 years of experience) and met United Kingdom Parkinson’s Disease Society Brain Bank criteria (22). The enrolled participants were aged 60–80 years with more than 4 years of disease duration, on stable medication regimens, and right handed. Exclusionary criteria were as follows: atypical or secondary forms of parkinsonism, severe or unstable depression, anticholinergic medications, other medical or neurologic reasons for cognitive impairment, or contraindications to MRI. Twenty-seven right-handed healthy control (HC) participants were also recruited from the community and age matched to the participants with PD. The HC participants met the following inclusion criteria: no cognitive complaints, healthy cognition with Mini-Mental State Examination scores greater than 28, normal neurologic examinations, absence of known neurologic disorders (eg, brain tumors, epilepsy, and multiple sclerosis), and no contraindications to MRI.

Reduced Field-of-View Pulse Sequence for Diffusion MRI

A custom reduced field-of-view diffusion imaging pulse sequence (19,20) was used in the study to achieve high spatial resolution in the brainstem (Fig 1). Central to the pulse sequence was a two-dimensional radiofrequency excitation pulse that was designed by using a tilted excitation k-space trajectory to enable multisection imaging (1719). To achieve this, a square k-space trajectory was first designed in the plane defined by the phase-encoding and section-selection directions. The square k-space trajectory was then rotated by 60° in plane, followed by scaling through changing the relative amplitude of the phase-encoding and section-selection gradients to achieve an optimal excitation k-space coverage (20). The two-dimensional radiofrequency pulse, which used a fly-back scheme to avoid issues associated with Nyquist ghosts, was incorporated into a diffusion-weighted single-shot echo-planar imaging pulse sequence with a subsequent radiofrequency refocusing pulse to achieve fat suppression (20).

Figure 1:

Figure 1:

Diagram shows reduced field-of-view pulse sequence (top) used in this study and its two-dimensional (2D) radiofrequency (RF) pulse (middle). For the RF pulse, the period of the accompanying gradient was 1.4 msec and 11 subpulses were used. The k-space trajectory was first designed as a square in the plane defined by the phase-encoding (ky) and section-selection (kz) directions, and then rotated by 60° in plane, followed by scaling the relative amplitude of the phase-encoding and section-selection gradients to achieve an optimal excitation k-space coverage (bottom). Note that the 2D RF pulse used a fly-back design to avoid the issues associated with Nyquist ghosts. EPI = echo-planar imaging, Gdiff = diffusion gradient, Gpe = phase-encoding gradient, Gss = section-selection gradient.

Image Acquisition

The pulse sequence in Figure 1a was implemented by using a 3.0-T imager (MR750; GE Healthcare, Waukesha, Wis). All participants were imaged with a 32-channel head coil (Nova Medical, Wilmington, Mass). The imaging protocol included noncontrast agent–enhanced sagittal T1-weighted imaging and axial T2-weighted fast spin-echo imaging with full brain coverage, followed by diffusion imaging with seven b values (0, 50, 200, 500, 1000, 2000, and 3000 sec/mm2, with four, two, two, four, four, four and four signal averages, respectively) over a small field of view of 10 × 6 cm2 in the axial plane covering the brainstem. At each nonzero b value, the diffusion gradient was applied successively along the three orthogonal directions to obtain a trace-weighted image to mitigate the effects of diffusion anisotropy. The other key acquisition parameters for the diffusion examination were as follows: repetition time msec/echo time msec, 3080/86; diffusion gradient separation, 47.0 msec; diffusion gradient pulse width, 32.2 msec; section thickness, 3 mm; intersection spacing, 0 mm; number of sections, 26; 160 × 96 matrix; voxel size, 0.6 × 0.6 × 3 mm3; and total examination time, approximately 3.5 minutes.

Diffusion Image Analysis

The reduced field-of-view diffusion-weighted images were reconstructed off-line by using customized software (Matlab; Mathworks, Natick, Mass). Complex signal averaging was used in the image reconstruction to increase the signal-to-noise ratio (20). After reconstruction of the individual images acquired with different gradient orientations, trace-weighted diffusion images were obtained and analyzed by using a conventional Gaussian monoexponential model and a non-Gaussian CTRW model, respectively.

In the Gaussian diffusion model, ADC was obtained from a monoexponential fitting with the following equation:

graphic file with name radiol.2019181042.eq1.jpg

by using two b values of 50 and 1000 sec/mm2, where S is the signal intensity acquired at b, S0 is the signal intensity without diffusion weighting, exp is an exponential function, and b is the b value. ADC calculation with higher b values (eg, 3000 sec/mm2) was not attempted because of considerable deviation from Gaussian diffusion.

In the CTRW model, the signal intensity in diffusion-weighted imaging normalized to S0 is described by a Mittag-Leffler function Eα:

graphic file with name radiol.2019181042.eq2.jpg

where b is the b value, Dm is an anomalous diffusion coefficient, and α and β are parameters related to temporal and spatial diffusion heterogeneities, respectively, as further explained in reference (14). Equation (2) was used to fit to the multiple-b-value diffusion images, pixel by pixel, by using an iterative Levenberg-Marquardt method in the Matlab Optimization Toolbox (Mathworks).

For each participant, regions of interest were drawn bilaterally on the hypointense region of the SN by using the images with a b value of 0 (Fig 2; regions of interest were drawn by Z.Z. with the supervision of two neuroradiologists who had more than 8 years of experience, on the basis of their mutual agreement). The structure of SN was identified in at least three contiguous sections, and the middle section was chosen to draw the regions of interest to minimize partial-volume effects. A region of interest of a similar size was also drawn on the midbrain tegmentum as an internal reference (bottom row in Fig 2). After obtaining the pixel-by-pixel parameter maps by using Equation (1) or (2), the mean values of Dm, α, β, and ADC within each region of interest were calculated for each participant and used for bilateral and unilateral comparisons.

Figure 2:

Figure 2:

Images (b = 0 sec/mm2) with the regions of interest (ROI) used in the image analysis. Bilateral ROIs were placed on the right and left substantia nigra (SN) separately (top), and an additional ROI in the tegmentum (bottom) was used as an internal reference in the comparisons.

Statistical Analysis

Statistical analyses were performed by using software (SPSS version 24.0; IBM, Armonk, NY) for both bilateral and unilateral SN comparisons between the PD and HC groups. In the bilateral comparison, the right and left regions of interest in the SN were combined for each participant, and an average value from the combined region of interest for each diffusion parameter was obtained. The mean value from all participants in each group was computed and used to detect the difference between the PD and HC groups by using a two-tailed Student t test; P values less than .05 indicated statistical significance. A multivariate analysis of variance was also performed to test for statistically significant difference between the PD and HC groups by using the combination of all CTRW parameters. For validation, the same statistical analyses were performed on the internal reference tegmentum to confirm the absence of other confounding factors that might lead to false-positive findings.

To investigate the unilateral abnormalities in the SN, the right and left regions of interest in Figure 2 were treated separately. A preliminary two-way mixed analysis of variance was first performed to examine whether there were significant group interactions between the SN side (ie, right SN and left SN) and the participant type (ie, participant with PD and HC participant). After confirming significant group interactions between the two factors, a post hoc analysis of the simple main effects was performed to investigate the unilateral difference between the PD and HC groups by using a two-tailed Student t test.

On the side of the SN that exhibited a statistically significant difference between the PD and HC groups, a receiver operating characteristic (ROC) analysis was performed by using the individual and the combination of CTRW parameters and ADC to identify unilateral SN abnormality. The combination of the three CTRW parameters (Dm, α, and β) was accomplished by using a multivariable logistic regression analysis according to the following function:

graphic file with name radiol.2019181042.eq3.jpg

where P0 is the probability of detecting the abnormality; exp is an exponential function; a0 is a constant; and a1, a2, and a3 are the regression coefficients of the corresponding CTRW parameters Dm, α, and β, respectively. The probability P0 was then used as a test variable in the ROC analysis. Additional ROC analyses were performed analogously to investigate other combinations, such as Dm and α, α and β, and Dm and β. Youden index was used to determine the best cut-off sensitivity and specificity of each ROC curve, together with the diagnostic accuracy and the area under the curve to identify unilateral SN abnormality in participants with PD.

Results

Image data from seven participants with PD were excluded from the analysis because of excessive motion during the MRI. Data from the remaining 27 participants with PD were analyzed and compared with those from the 27 HC participants. The characteristics of all participants are summarized in Table 1. The mean age of participants with PD was 71.2 years ± 6.3 (standard deviation); the mean age of HC participants was 69.7 years ± 5.6. The average duration of disease for patients with PD was 11.4 years.

Table 1:

Participant Characteristics

graphic file with name radiol.2019181042.tbl1.jpg

Note.—Mean data are ± standard deviation; data in parentheses are range. HC = healthy control, MDS-UPDRS = Movement Disorder Society Unified Parkinson’s Disease Rating Scale, NA = not applicable, PD = Parkinson disease, PDD = Parkinson disease dementia, PD-MCI = Parkinson disease mild cognitive impairment, PD-NCI = Parkinson disease no cognitive impairment.

*Side of onset was determined by patient report and record review.

Representative Diffusion-weighted Images and Diffusion Parameter Maps

Representative diffusion-weighted images of the brainstem from a participant with PD and an HC participant are shown on the top row of Figure 3, where structures in the brainstem were resolved with high spatial resolution (voxel size, 0.6 × 0.6 × 3 mm3) and in the absence of visible image distortion. The other images on Figure 3 show a set of maps of Dm, α, β, and ADC obtained in the same participants. ADC within the brainstem was higher than Dm, which was likely because of the non-Gaussian behavior that was not accounted for in the ADC calculation.

Figure 3:

Figure 3:

A set of representative axial diffusion-weighted (DW) images and different diffusion parameter maps from a patient with Parkinson disease (PD; 71-year-old man with PD duration of 10 years) and a healthy control (HC) participant (71-year-old man). The DW MR images (DW imaging; b = 1000 sec/mm2; top row) illustrate high spatial resolution and absence of image distortion achieved by the reduced field-of-view pulse sequence in Figure 1. α = temporal diffusion heterogeneity index, β = spatial diffusion heterogeneity index, ADC = apparent diffusion coefficient, Dm = anomalous diffusion coefficient.

Bilateral SN Comparison between the PD and HC Groups

In the bilateral comparison between the PD and HC groups, lower ADC (P = .03) and higher β (P = .016) were observed in the PD group compared with the HC group (Table 2). Although Dm (P = .12) and α (P = .13) did not exhibit a difference between the two groups, the combination of the three CTRW parameters showed a difference (P = .02) as revealed by the multivariate analysis of variance analysis. In all comparisons, no difference was observed in the midbrain tegmentum, which was the internal reference (P > .05).

Table 2:

Bilateral Substantia Nigra Comparison

graphic file with name radiol.2019181042.tbl2.jpg

Note.—Unless otherwise indicated, data are mean ± standard deviation. Comparison was performed between the Parkinson disease and healthy control groups by using a two-tailed Student t test for each individual Gaussian and non-Gaussian diffusion parameter. α = temporal diffusion heterogeneity index, β = spatial diffusion heterogeneity index, ADC = apparent diffusion coefficient, CTRW = continuous-time random walk, Dm = anomalous diffusion coefficient, HC = health control, MANOVA = multivariate analysis of variance, PD = Parkinson disease.

*P value indicates statistical significance.

Unilateral SN Comparison between the PD and HC Groups

The preliminary two-way mixed analysis of variance showed significant group interactions between the SN side and the participant type (typical P < .02), which provided the justification to use a post hoc analysis of simple main effects to investigate the differences between the PD and HC groups on each side. To establish a reference in unilateral comparison, the right and left sides of SN were first compared within the HC group, which showed no lateral difference in any of the diffusion parameters (P > .67; Fig 4). Unilateral differences between the PD and HC groups were observed in the left side (P < .03), but not in the right (P > .20) for each of the three CTRW parameters and for the ADC (Fig 5). This observation was further substantiated by significant correlations between two diffusion parameters and the motor score only on the left side of SN (ADC, r = −0.384, P = .047; and β, r = 0.390, P = .04). The results in Figure 5 also indicated that the bilateral differences between the PD and HC groups, summarized in Table 2, arose primarily from the left SN in the PD group. It is worth noting that α and Dm showed differences in the unilateral comparison in the left side, but not in the bilateral comparison (Table 2), which is likely because of averaging with the noncontributing right side. For the comparisons that did not show significance, a power analysis was performed to determine the minimum detectable differences (Appendix E1 [online]).

Figure 4:

Figure 4:

Box plots of unilateral comparison between the left and right side of substantia nigra within the healthy control (HC) group for individual Gaussian or non-Gaussian diffusion parameters. No significant difference was observed in any of the four parameters, which is indicated by the P values. The dotted vertical lines indicate the range of the data. The mean value and standard deviation of the diffusion parameters for the right and left substantia nigra in the HC group were as follows: temporal diffusion heterogeneity index (α), 0.87 ± 0.05 versus 0.88 ± 0.05, respectively; spatial diffusion heterogeneity index (β), 0.64 ± 0.06 versus 0.63 ± 0.05, respectively; anomalous diffusion coefficient (Dm), 0.33 μm2/msec ± 0.07 versus 0.32 μm2/msec ± 0.06, respectively; and apparent diffusion coefficient (ADC), 0.52 μm2/msec ± 0.08 versus 0.53 μm2/msec ± 0.07, respectively.

Figure 5:

Figure 5:

Box plots of unilateral comparison between the Parkinson disease (PD) and healthy control (HC) groups with different diffusion parameters. The unilateral difference was observed on the left side of the substantia nigra (SN; top), but not on the right (bottom) between the PD and HC groups for each of the four diffusion parameters: temporal diffusion heterogeneity index (α), spatial diffusion heterogeneity index (β), anomalous diffusion coefficient (Dm), and apparent diffusion coefficient (ADC). The P value in each comparison is indicated, and bold denotes that the P value was indicative of statistical significance (P < .05). The dotted vertical lines indicate the range of the data.

ROC Analyses on the Left SN Changes in PD Patients

At the ROC analyses (Table 3), ADC produced the best accuracy (38 of 54 [70.4%]) and the best specificity (44 of 54 [81.5%]) among individual parameters for identifying the changes on the left side of SN. When individual CTRW parameters were used, α provided the best sensitivity (40 of 54 [74.1%]), diagnostic accuracy (38 of 54 [70.4%]), and the area under the curve (area under the curve, 0.68); Dm produced the best specificity (38 of 54 [70.4%]). Compared with ADC, only α had a higher sensitivity and a comparable diagnostic accuracy.

Table 3:

Receiver Operating Characteristic Curve Analysis

graphic file with name radiol.2019181042.tbl3.jpg

Note.—Unless otherwise indicated, data are numerator/denominator and data in parentheses are percentages. Analysis is based on the changes in the left side of the substantia nigra. α = temporal diffusion heterogeneity index, β = spatial diffusion heterogeneity index, ADC = apparent diffusion coefficient, Dm = anomalous diffusion coefficient.

* Data in parentheses are 95% confidence intervals.

Best value of sensitivity, specificity, or accuracy among all receiver operating characteristic curves.

Largest area under the receiver operating characteristic curve in the column.

When the CTRW parameters were combined, the performance was notably improved. Among the four combinations, the combination of Dm, α, and β produced the best sensitivity (42 of 54 [77.8%]), the combination of Dm and β yielded the best specificity (46 of 54 [85.2%]), and the combination of α and β yielded the largest area under the curve (area under the curve, 0.73). Overall, ADC produced one of the best diagnostic accuracies, whereas the combinations of the CTRW parameters provided more balanced sensitivity and specificity. The ROC curves of two representative combinations of CTRW parameters, the combination of Dm, α, and β and the combination of α and β, together with ADC, are shown in Figure 6.

Figure 6:

Figure 6:

Selected receiver operating characteristic curves by using the left substantia nigra diffusion parameters for detection of Parkinson disease. Two combinations of continuous-time random-walk parameters, anomalous diffusion coefficient (Dm), temporal diffusion heterogeneity index (α), and spatial diffusion heterogeneity index (β), and α and β, as well as the apparent diffusion coefficient (ADC) were selected to identify the abnormality on the left side of substantia nigra in the Parkinson disease group compared with the healthy control group. The sensitivity, specificity, diagnostic accuracy, and area under the curve are summarized in Table 3.

Discussion

By using high-spatial-resolution reduced field-of-view diffusion MRI with Gaussian and non-Gaussian diffusion models, we observed significant differences only on the left SN between the PD and HC groups. This suggests that the unilateral difference is the major contributor to the bilateral difference observed in our study and reported by others (7,8,23).

Handedness has been proposed as a possible cause to explain this asymmetry (24). In our study, all participants were right handed, which can explain the observed unilateral difference only on the left side of the SN. This explanation is consistent with previous studies that reported a significant association between the handedness and the side of the initial motor symptom (1), and the dominant side of symptom in patients with PD (25). Another study that used SPECT reported left hemispheric predominance of nigrostriatal dysfunction among right-handed patients with PD, further suggesting that hemispheric asymmetry plays an important role in the development of PD (3). Even though handedness may not be the only reason, the results of our study indicate that it can be an important factor for understanding the unilateral structural alteration in the SN in patients with PD.

Dopaminergic neuronal degeneration in the SN can lead to the underlying tissue microstructural alterations. These tissue structural alterations can be effectively probed with diffusion MRI. For example, fractional anisotropy changes revealed by diffusion-tensor imaging have been reported in the SN (68); however, the reported trends for fractional anisotropy change are inconsistent (68,26,27). Water diffusivity, measured by ADC or mean diffusivity, has also been used to investigate possible changes in the SN of patients with PD. Most of these studies did not find a significant difference between participants with PD and HC participants (2729), whereas other studies reported higher (6,30) or lower (7) diffusivity in patients with PD. The inadequate spatial resolution (eg, ∼2 × 2 × 2 mm3) that prevents a more sensitive unilateral analysis in these studies can be a possible explanation of the inconsistent findings.

Unlike previously published studies, we used a high-spatial-resolution diffusion MRI technique with reduced field of view that allowed us to investigate the unilateral as well as bilateral differences in the SN in patients with PD. The spatial resolution used in this study (voxel size, 0.6 × 0.6 × 3 mm3) is, to our knowledge, among the highest ever applied to PD by using diffusion MRI and is particularly important for imaging small structures such as the SN by substantially reducing the partial-volume effects. By using high-spatial-resolution diffusion imaging, a reduction in ADC was observed only on the left side of the SN in the PD group compared with the HC group. This is an indication of a more restricted diffusion environment possibly because of increased cellularity or cell volume fraction related to the formation of Lewy bodies, the glial response to the neuronal loss in SN (mainly microglial cells and to a lesser extent reactive astrocytes), and neuroinflammation when neuromelanin-containing neurons die and neuromelanin granules are released into the extracellular space (31).

The non-Gaussian CTRW model and its variations were successfully applied to tissue characterization in cancer imaging studies (11,14,3234). This model offers three parameters: Dm, α, and β. Unlike ADC, Dm accounts for non-Gaussian diffusion behavior in biologic tissues. The smaller Dm and ADC observed in our study are in agreement with a report on SN in PD (7). α and β have been associated with the temporal and spatial diffusion heterogeneity, respectively (14), both of which may reflect different aspects of intravoxel tissue structural heterogeneity. The smaller α on the left side of SN in the PD group suggests that water molecules are diffusing through a more heterogeneous environment temporally (ie, water molecules take a variable amount of time to make a move), whereas the increased β indicates a spatially more homogeneous environment (ie, the water molecules diffuse with a more uniform step length in each move). The different trend of the diffusion parameters can be a reflection of the compounded microstructural changes related to PD such as neuronal loss and reactive gliosis. An additional value of non-Gaussian CTRW diffusion imaging is that it combines multiple diffusion parameters because of their complementary roles in describing complex diffusion processes. The combinations of two or three CTRW parameters provide multiple possibilities to complement ADC in improving sensitivity and specificity.

Our study had limitations. One limitation is the lack of comparison with a group of left-handed participants because of the small occurrence in the general population (<10%) (35), which makes it difficult to recruit a sufficient number of participants with PD. The limited number of participants also prevented us from performing an independent validation in the ROC analysis. Another limitation was that the reported unilateral alterations in diffusion parameters were not validated by or correlated with another independent method such as histopathologic analysis. Thus, the exact tissue structural underpinning of the observed changes, to our knowledge, remains unknown. Finally, the accuracy of our quantitative analysis was negatively affected by the relatively low signal-to-noise ratio in the diffusion-weighted images because of simultaneous increases in spatial resolution and b value. The signal-to-noise ratio limitation forced us to use a relatively thick section compared with the high in-plane resolution. However, the use of a 32-channel coil together with signal averaging helped to alleviate this problem.

In conclusion, our results provided in vivo neuroimaging evidence of substantia nigra lateral asymmetry in patients with Parkinson disease and suggested a set of diffusion imaging markers for characterizing such asymmetry.

APPENDIX

Appendix E1 (PDF)
ry181042suppa1.pdf (159KB, pdf)

Acknowledgments

Acknowledgments

The authors are grateful to Ping-Shou Zhong, PhD, and Glenn Stebbins, PhD, for advising on statistical analysis, Dr. Liping Qi, MD, for helpful discussions, and Michael Flannery, BS, and Hagai Ganin, BA, for technical assistance.

Study supported by Michael J. Fox Foundation for Parkinson's Research and the National Institutes of Health (NIH 1S10RR028898, NIH K23NS060949, NIH R01EB026716).

Disclosures of Conflicts of Interest: Z.Z. disclosed no relevant relationships. D.M. disclosed no relevant relationships. M.M.K. disclosed no relevant relationships. J.Z. disclosed no relevant relationships. Y.S. disclosed no relevant relationships. J.G.G. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed money paid to author for consultancies from Acadia, Aptinyx, and Sunovion; payment to author’s institution for grants/grants pending from CHDI, Biogen, and Consolidated Antiaging Foundation; payment to author for lectures including service on speakers bureaus from American Academy of Neurology and International Parkinson’s Disease and Movement Disorders Society; money paid to author for development of educational presentations from MedEdicus; and travel/accommodations/meeting expenses from the American Academy of Neurology and the Movement Disorder Society. Other relationships: disclosed no relevant relationships. X.J.Z. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed board directorship on the American Board of Medical Physics; disclosed money paid to author for ownership and consultancy from Horizon Medical Physics Services; disclosed grants/grants pending from Abbvie; disclosed royalties from Elsevier; disclosed issued U.S. patent number 9 797 970. Other relationships: disclosed no relevant relationships.

Abbreviations:

α
temporal diffusion heterogeneity index
β
spatial diffusion heterogeneity index
ADC
apparent diffusion coefficient
CTRW
continuous-time random walk
Dm
anomalous diffusion coefficient
HC
healthy control
PD
Parkinson disease
ROC
receiver operating characteristic
SN
substantia nigra

References

  • 1.Barrett MJ, Wylie SA, Harrison MB, Wooten GF. Handedness and motor symptom asymmetry in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2011;82(10):1122–1124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kempster PA, Gibb WR, Stern GM, Lees AJ. Asymmetry of substantia nigra neuronal loss in Parkinson’s disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry 1989;52(1):72–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Scherfler C, Seppi K, Mair KJ, et al. Left hemispheric predominance of nigrostriatal dysfunction in Parkinson’s disease. Brain 2012;135(Pt 11):3348–3354. [DOI] [PubMed] [Google Scholar]
  • 4.Cosottini M, Frosini D, Pesaresi I, et al. MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. Radiology 2014;271(3):831–838. [DOI] [PubMed] [Google Scholar]
  • 5.Schwarz ST, Afzal M, Morgan PS, Bajaj N, Gowland PA, Auer DP. The ‘swallow tail’ appearance of the healthy nigrosome - a new accurate test of Parkinson’s disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS One 2014;9(4):e93814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Schwarz ST, Abaei M, Gontu V, Morgan PS, Bajaj N, Auer DP. Diffusion tensor imaging of nigral degeneration in Parkinson’s disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin 2013;3:481–488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Langley J, Huddleston DE, Merritt M, et al. Diffusion tensor imaging of the substantia nigra in Parkinson’s disease revisited. Hum Brain Mapp 2016;37(7):2547–2556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vaillancourt DE, Spraker MB, Prodoehl J, et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009;72(16):1378–1384 [Published correction appears in Neurology 2009;72(23):2059.]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Meijer FJA, Bloem BR, Mahlknecht P, Seppi K, Goraj B. Update on diffusion MRI in Parkinson’s disease and atypical parkinsonism. J Neurol Sci 2013;332(1-2):21–29. [DOI] [PubMed] [Google Scholar]
  • 10.Zhou XJ, Gao Q, Abdullah O, Magin RL. Studies of anomalous diffusion in the human brain using fractional order calculus. Magn Reson Med 2010;63(3):562–569. [DOI] [PubMed] [Google Scholar]
  • 11.Sui Y, Wang H, Liu G, et al. Differentiation of low- and high-grade pediatric brain tumors with high b-value diffusion-weighted MR imaging and a fractional order calculus model. Radiology 2015;277(2):489–496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005;53(6):1432–1440. [DOI] [PubMed] [Google Scholar]
  • 13.Assaf Y, Mayk A, Cohen Y. Displacement imaging of spinal cord using q-space diffusion-weighted MRI. Magn Reson Med 2000;44(5):713–722. [DOI] [PubMed] [Google Scholar]
  • 14.Karaman MM, Sui Y, Wang H, Magin RL, Li Y, Zhou XJ. Differentiating low- and high-grade pediatric brain tumors using a continuous-time random-walk diffusion model at high b-values. Magn Reson Med 2016;76(4):1149–1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Karaman MM, Zhou XJ. A fractional motion diffusion model for a twice-refocused spin-echo pulse sequence. NMR Biomed 2018;31(11):e3960. [DOI] [PubMed] [Google Scholar]
  • 16.Assaf Y, Basser PJ. Composite hindered and restricted model of diffusion (CHARMED) MR imaging of the human brain. Neuroimage 2005;27(1):48–58. [DOI] [PubMed] [Google Scholar]
  • 17.Finsterbusch J. Improving the performance of diffusion-weighted inner field-of-view echo-planar imaging based on 2D-selective radiofrequency excitations by tilting the excitation plane. J Magn Reson Imaging 2012;35(4):984–992. [DOI] [PubMed] [Google Scholar]
  • 18.Saritas EU, Cunningham CH, Lee JH, Han ET, Nishimura DG. DWI of the spinal cord with reduced FOV single-shot EPI. Magn Reson Med 2008;60(2):468–473. [DOI] [PubMed] [Google Scholar]
  • 19.Zhou XJ, Sui Y. Image domain segmented echo planar magnetic resonance imaging using a 2D excitation radiofrequency pulse. U.S. Patent No 9797970 B2. 2017. [Google Scholar]
  • 20.Sui Y, Damen F, Xie K, Zhou XJ. Image domain segmented diffusion imaging using a 2D excitation RF pulse for distortion reduction [abstr]. In: Proceedings of the Twenty-Second Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2014; 0608. [Google Scholar]
  • 21.Goldman JG, Ghode RA, Ouyang B, Bernard B, Goetz CG, Stebbins GT. Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson’s disease. Parkinsonism Relat Disord 2013;19(9):806–811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55(3):181–184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Azuma M, Hirai T, Yamada K, et al. Lateral asymmetry and spatial difference of iron deposition in the substantia nigra of patients with Parkinson disease measured with quantitative susceptibility mapping. AJNR Am J Neuroradiol 2016;37(5):782–788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Melamed E, Poewe W. Taking sides: is handedness involved in motor asymmetry of Parkinson’s disease? Mov Disord 2012;27(2):171–173. [DOI] [PubMed] [Google Scholar]
  • 25.Shi J, Liu J, Qu Q. Handedness and dominant side of symptoms in Parkinson’s disease. Med Clin (Barc) 2014;142(4):141–144. [DOI] [PubMed] [Google Scholar]
  • 26.Schuff N, Wu IW, Buckley S, et al. Diffusion imaging of nigral alterations in early Parkinson’s disease with dopaminergic deficits. Mov Disord 2015;30(14):1885–1892. [DOI] [PubMed] [Google Scholar]
  • 27.Prakash BD, Sitoh YY, Tan LC, Au WL. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson’s disease. Parkinsonism Relat Disord 2012;18(9):1029–1033. [DOI] [PubMed] [Google Scholar]
  • 28.Wang JJ, Lin WY, Lu CS, et al. Parkinson disease: diagnostic utility of diffusion kurtosis imaging. Radiology 2011;261(1):210–217. [DOI] [PubMed] [Google Scholar]
  • 29.Van Camp N, Blockx I, Verhoye M, et al. Diffusion tensor imaging in a rat model of Parkinson’s disease after lesioning of the nigrostriatal tract. NMR Biomed 2009;22(7):697–706. [DOI] [PubMed] [Google Scholar]
  • 30.Péran P, Cherubini A, Assogna F, et al. Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain 2010;133(11):3423–3433. [DOI] [PubMed] [Google Scholar]
  • 31.Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007;8(1):57–69. [DOI] [PubMed] [Google Scholar]
  • 32.Sui Y, Xiong Y, Jiang J, et al. Differentiation of low- and high-grade gliomas using high b-value diffusion imaging with a non-gaussian diffusion model. AJNR Am J Neuroradiol 2016;37(9):1643–1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Karaman MM, Wang H, Sui Y, Engelhard HH, Li Y, Zhou XJ. A fractional motion diffusion model for grading pediatric brain tumors. Neuroimage Clin 2016;12:707–714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Tang L, Sui Y, Zhong Z, et al. Non-Gaussian diffusion imaging with a fractional order calculus model to predict response of gastrointestinal stromal tumor to second-line sunitinib therapy. Magn Reson Med 2018;79(3):1399–1406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sun T, Walsh CA. Molecular approaches to brain asymmetry and handedness. Nat Rev Neurosci 2006;7(8):655–662. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Appendix E1 (PDF)
ry181042suppa1.pdf (159KB, pdf)

Articles from Radiology are provided here courtesy of Radiological Society of North America

RESOURCES